Biomanufacturing Excellence Act of 2025

Key Points

• Congress would direct the National Institute of Standards and Technology to pick one non-federal group to run a national center focused on making medicines using living cells.
• The center would work on “how to scale up” drug manufacturing—moving ideas from a lab into reliable, large-scale production—so the US is less dependent on foreign supply chains.
• It would support better manufacturing standards and shared best practices, aiming to make new drug-making methods more consistent and easier for regulators to review.
• It would help train workers—partnering with colleges and community groups—so more people can operate specialized biotech tools and equipment.
• The bill authorizes $120 million for fiscal year 2026 to help build facilities, run research partnerships, and support training programs.